Mechanisms of bacterial lipopolysaccharide-induced endothelial apoptosis

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 284, Issue 6 28-6, 2003, Pages

  Bannerman, Douglas D ^a   Goldblum, Simeon E ^b  

^a AGRICULTURAL RESEARCH SERVICE   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Endotoxin; Inflammation; Nuclear factor B; Sepsis; Vascular injury

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; CASPASE; CELL ADHESION MOLECULE; CYTOKINE; ENDOTOXIN; FLICE INHIBITORY PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NITRIC OXIDE; PROTEIN BCL 2; REACTIVE OXYGEN METABOLITE; THROMBOPLASTIN; TOLL LIKE RECEPTOR 4;

APOPTOSIS; CYTOKINE RELEASE; ENDOTHELIUM CELL; ENDOTHELIUM INJURY; GRAM NEGATIVE BACTERIUM; NICK END LABELING; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; RESPIRATORY DISTRESS SYNDROME; REVIEW; SEPSIS; SIGNAL TRANSDUCTION;

EID: 0038173259     PISSN: 10400605     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajplung.00338.2002     Document Type: Review

References (225)

1. Abello PA, Fidler SA, Bulkley GB, and Buchman TG. Antioxidants modulate induction of programmed endothelial cell death (apoptosis) by endotoxin. Arch Surg 129: 134-140, 1994.
2. Adams JM and Cory S. The Bcl-2 protein family: arbiters of cell survival. Science 281: 1322-1326, 1998.
3. Akashi S, Ogata H, Kirikae F, Kirikae T, Kawasaki K, Nishijima M, Shimazu R, Nagai Y, Fukudome K, Kimoto M, and Miyake K. Regulatory roles for CD14 and phosphatidylinositol in the signaling via Toll-like receptor 4-MD-2. Biochem Biophys Res Commun 268: 172-177, 2000.
4. Aliprantis AO, Yang RB, Mark MR, Suggett S, Devaux B, Radolf JD, Klimpel GR, Godowski P, and Zychlinsky A. Cell activation and apoptosis by bacterial lipoproteins through Toll-like receptor-2. Science 285: 736-739, 1999.
5. Aliprantis AO, Yang RB, Weiss DS, Godowski P, and Zychlinsky A. The apoptotic signaling pathway activated by Toll-like receptor-2. EMBO J 19: 3325-3336, 2000.
6. Alpert G, Baldwin G, Thompson C, Wainwright N, Novitsky TJ, Gillis Z, Parsonnet J, Fleisher GR, and Siber GR. Limulus antilipopolysaccharide factor protects rabbits from meningococcal endotoxin shock. J Infect Dis 165: 494-500, 1992.
7. Anrather J, Csizmadia V, Brostjan C, Soares MP, Bach FH, and Winkler H. Inhibition of bovine endothelial cell activation in vitro by regulated expression of a transdominant inhibitor of NF-κB. J Clin Invest 99: 763-772, 1997.
8. Antonsson B and Martinou JC. The Bcl-2 protein family. Exp Cell Res 256: 50-57, 2000.
9. Arditi M, Zhou J, Dorio R, Rong GW, Goyert SM, and Kim KS. Endotoxin-mediated endothelial cell injury and activation: role of soluble CD14. Infect Immun 61: 3149-3156, 1993.
10. Armstrong JS, Steinauer KK, Hornung B, Irish JM, Lecane P, Birrell GW, Peehl DM, and Knox SJ. Role of glutathione depletion and reactive oxygen species generation in apoptotic signaling in a human B lymphoma cell line. Cell Death Differ 9: 252-263, 2002.
11. Ashkenazi A and Dixit VM. Death receptors: signaling and modulation. Science 281: 1305-1308, 1998.
12. Assaly R, Olson D, Hammersley J, Fan PS, Liu J, Shapiro JI, and Kahaleh MB. Initial evidence of endothelial cell apoptosis as a mechanism of systemic capillary leak syndrome. Chest 120: 1301-1308, 2001.
13. Badrichani AZ, Stroka DM, Bilbao G, Curiel DT, Bach FH, and Ferran C. Bcl-2 and Bcl-XL serve an anti-inflammatory function in endothelial cells through inhibition of NF-κB. J Clin Invest 103: 543-553, 1999.
14. Balis JU, Gerber LI, Rappaport ES, and Neville WE. Mechanisms of blood-vascular reactions of the primate lung to acute endotoxemia. Exp Mol Pathol 21: 123-137, 1974.
15. Bannerman DD, Erwert RD, Winn RK, and Harlan JM. TIRAP mediates endotoxin-induced NF-κB activation and apoptosis in endothelial cells. Biochem Biophys Res Commun 295: 157-162, 2002.
16. Bannerman DD, Fitzpatrick MJ, Anderson DY, Bhattacharjee AK, Novitsky TJ, Hasday JD, Cross AS, and Goldblum SE. Endotoxin-neutralizing protein protects against endotoxin-induced endothelial barrier dysfunction. Infect Immun 66: 1400-1407, 1998.
17. Bannerman DD and Goldblum SE. Direct effects of endotoxin on the endothelium: barrier function and injury. Lab Invest 79: 1181-1199, 1999.
18. Bannerman DD, Sathyamoorthy M, and Goldblum SE. Bacterial lipopolysaccharide disrupts endothelial monolayer integrity and survival signaling events through caspase cleavage of adherens junction proteins. J Biol Chem 273: 35371-35380, 1998.
19. Bannerman DD, Tupper JC, Erwert RD, Winn RK, and Harlan JM. Divergence of bacterial lipopolysaccharide proapoptotic signaling downstream of IRAK-1. J Biol Chem 277: 8048-8053, 2002.
20. Bannerman DD, Tupper JC, Kelly JD, Winn RK, and Harlan JM. The Fas-associated death domain protein suppresses activation of NF-κB by LPS and IL-1β. J Clin Invest 109: 419-425, 2002.
21. Bannerman DD, Tupper JC, Ricketts WA, Bennett CF, Winn RK, and Harlan JM. A constitutive cytoprotective pathway protects endothelial cells from lipopolysaccharide-induced apoptosis. J Biol Chem 276: 14924-14932, 2001.
22. Beal AL and Cerra FB. Multiple organ failure syndrome in the 1990s. Systemic inflammatory response and organ dysfunction. JAMA 271: 226-233, 1994.
23. Bell RC, Coalson JJ, Smith JD, and Johanson WG Jr. Multiple organ system failure and infection in adult respiratory distress syndrome. Ann Intern Med 99: 293-298, 1983.
24. Bodmer JL, Holler N, Reynard S, Vinciguerra P, Schneider P, Juo P, Blenis J, and Tschopp J. TRAIL receptor-2 signals apoptosis through FADD and caspase-8. Nat Cell Biol 2: 241-243, 2000.
25. Borutaite V and Brown GC. Caspases are reversibly inactivated by hydrogen peroxide. FEBS Lett 500: 114-118, 2001.
26. Brandtzaeg P, Kierulf P, Gaustad P, Skulberg A, Bruun JN, Halvorsen S, and Sorensen E. Plasma endotoxin as a predictor of multiple organ failure and death in systemic meningococcal disease. J Infect Dis 159: 195-204, 1989.
27. Brigham KL and Meyrick B. Endotoxin and lung injury. Am Rev Respir Dis 133: 913-927, 1986.
28. Brigham KL, Meyrick B, Berry LC Jr, and Repine JE. Antioxidants protect cultured bovine lung endothelial cells from injury by endotoxin. J Appl Physiol 63: 840-850, 1987.
29. Brown GC and Borutaite V. Nitric oxide, cytochrome c and mitochondria. Biochem Soc Symp 66: 17-25, 1999.
30. Cai W, Devaux B, Schaper W, and Schaper J. The role of Fas/APO 1 and apoptosis in the development of human atherosclerotic lesions. Atherosclerosis 131: 177-186, 1997.
31. Ceneviva GD, Tzeng E, Hoyt DG, Yee E, Gallagher A, Engelhardt JF, Kim YM, Billiar TR, Watkins SA, and Pitt BR. Nitric oxide inhibits lipopolysaccharide-induced apoptosis in pulmonary artery endothelial cells. Am J Physiol Lung Cell Mol Physiol 275: L717-L728, 1998.
32. Chandra J, Samali A, and Orrenius S. Triggering and modulation of apoptosis by oxidative stress. Free Radic Biol Med 29: 323-333, 2000.
33. Chaudhary PM, Eby MT, Jasmin A, Kumar A, Liu L, and Hood L. Activation of the NF-κB pathway by caspase-8 and its homologs. Oncogene 19: 4451-4460, 2000.
34. Chen CC, Rosenbloom CL, Anderson DC, and Manning AM. Selective inhibition of E-selectin, vascular cell adhesion molecule-1, and intercellular adhesion molecule-1 expression by inhibitors of IκB-α phosphorylation. J Immunol 155: 3538-3545, 1995.
35. Chinnaiyan AM, Tepper CG, Seldin MF, O'Rourke K, Kischkel FC, Hellbardt S, Krammer PH, Peter ME, and Dixit VM. FADD/MORT1 is a common mediator of CD95 (Fas/APO-1) and tumor necrosis factor receptor-induced apoptosis. J Biol Chem 271: 4961-4965, 1996.
36. Choi KB, Wong F, Harlan JM, Chaudhary PM, Hood L, and Karsan A. Lipopolysaccharide mediates endothelial apoptosis by a FADD-dependent pathway. J Biol Chem 273: 20185-20188, 1998.
37. Chow JC, Young DW, Golenbock DT, Christ WJ, and Gusovsky F. Toll-like receptor-4 mediates lipopolysaccharide-induced signal transduction. J Biol Chem 274: 10689-10692, 1999.
38. Cines DB, Pollak ES, Buck CA, Loscalzo J, Zimmerman GA, McEver RP, Pober JS, Wick TM, Konkle BA, Schwartz BS, Barnathan ES, McCrae KR, Hug BA, Schmidt AM, and Stern DM. Endothelial cells in physiology and in the pathophysiology of vascular disorders. Blood 91: 3527-3561, 1998.
39. Clemens MJ, McNurlan MA, Moore G, and Tilleray VJ. Regulation of protein synthesis in lymphoblastoid cells during inhibition of cell proliferation by human interferons. FEBS Lett 171: 111-116, 1984.
40. Coalson JJ, Benjamin BA, Archer LT, Beller BK, Spaet RH, and Hinshaw LB. A pathologic study of Escherichia coli shock in the baboon and the response to adrenocorticosteroid treatment. Surg Gynecol Obstet 147: 726-736, 1978.
41. Coalson JJ, Hinshaw LB, Guenter CA, Berrell EL, and Greenfield LJ. Pathophysiologic responses of the subhuman primate in experimental septic shock. Lab Invest 32: 561-569, 1975.
42. Colucci M, Balconi G, Lorenzet R, Pietra A, Locati D, Donati MB, and Semeraro N. Cultured human endothelial cells generate tissue factor in response to endotoxin. J Clin Invest 71: 1893-1896, 1983.
43. Colussi PA and Kumar S. Targeted disruption of caspase genes in mice: what they tell us about the functions of individual caspases in apoptosis. Immunol Cell Biol 77: 58-63, 1999.
44. Cooper JT, Stroka DM, Brostjan C, Palmetshofer A, Bach FH, and Ferran C. A20 blocks endothelial cell activation through a NF-κB-dependent mechanism. J Biol Chem 271: 18068-18073, 1996.
45. Cox G, Crossley J, and Xing Z. Macrophage engulfment of apoptotic neutrophils contributes to the resolution of acute pulmonary inflammation in vivo. Am J Respir Cell Mol Biol 12: 232-237, 1995.
46. Curzen NP, Griffiths MJ, and Evans TW. Role of the endothelium in modulating the vascular response to sepsis. Clin Sci (Lond) 86: 359-374, 1994.
47. Cybulsky MI, Chan MK, and Movat HZ. Acute inflammation and microthrombosis induced by endotoxin, interleukin-1, and tumor necrosis factor and their implication in gram-negative infection. Lab Invest 58: 365-378, 1988.
48. Daun JM and Fenton MJ. Interleukin-1/Toll receptor family members: receptor structure and signal transduction pathways. J Interferon Cytokine Res 20: 843-855, 2000.
49. Deaciuc IV, Fortunato F, D'Souza NB, Hill DB, Schmidt J, Lee EY, and McClain CJ. Modulation of caspase-3 activity and Fas ligand mRNA expression in rat liver cells in vivo by alcohol and lipopolysaccharide. Alcohol Clin Exp Res 23: 349-356, 1999.
50. Delvos U, Janssen B, and Muller-Berghaus G. Effect of lipopolysaccharides on cultured human endothelial cells. Relationship between tissue factor activity and prostacyclin release. Blut 55: 101-108, 1987.
51. DeMeester SL, Qiu Y, Buchman TG, Hotchkiss RS, Dunnigan K, Karl IE, and Cobb JP. Nitric oxide inhibits stress-induced endothelial cell apoptosis. Crit Care Med 26: 1500-1509, 1998.
52. Desch CE, O'Hara P, and Harlan JM. Antilipopolysaccharide factor from horseshoe crab, Tachypleus tridentatus, inhibits lipopolysaccharide activation of cultured human endothelial cells. Infect Immun 57: 1612-1614, 1989.
53. Dimmeler S, Assmus B, Hermann C, Haendeler J, and Zeiher AM. Fluid shear stress stimulates phosphorylation of Akt in human endothelial cells: involvement in suppression of apoptosis. Circ Res 83: 334-341, 1998.
54. Dimmeler S, Haendeler J, Galle J, and Zeiher AM. Oxidized low-density lipoprotein induces apoptosis of human endothelial cells by activation of CPP32-like proteases. A mechanistic clue to the 'response to injury' hypothesis. Circulation 95: 1760-1763, 1997.
55. Dimmeler S, Haendeler J, Nehls M, and Zeiher AM. Suppression of apoptosis by nitric oxide via inhibition of interleukin-1β-converting enzyme (ICE)-like and cysteine protease protein (CPP)-32-like proteases. J Exp Med 185: 601-607, 1997.
56. Dimmeler S, Hermann C, Galle J, and Zeiher AM. Upregulation of superoxide dismutase and nitric oxide synthase mediates the apoptosis-suppressive effects of shear stress on endothelial cells. Arterioscler Thromb Vasc Biol 19: 656-664, 1999.
57. Dinarello CA. Proinflammatory and anti-inflammatory cytokines as mediators in the pathogenesis of septic shock. Chest 112: 321S-329S, 1997.
58. Dixit VM, Green S, Sarma V, Holzman LB, Wolf FW, O'Rourke K, Ward PA, Prochownik EV, and Marks RM. Tumor necrosis factor-α induction of novel gene products in human endothelial cells including a macrophage-specific chemotaxin. J Biol Chem 265: 2973-2978, 1990.
59. Engelberts I, van Hoof SC, Samyo SK, Buurman WA, and van der Linden CJ. Generalized inflammation during peritonitis evidenced by intracutaneous E-selectin expression. Clin Immunol Immunopathol 65: 330-334, 1992.
60. Erwert RD, Winn RK, Harlan JM, and Bannerman DD. Shiga-like toxin inhibition of FLICE-like inhibitory protein expression sensitizes endothelial cells to bacterial lipopolysaccharide-induced apoptosis. J Biol Chem 277: 40567-40574, 2002.
61. Faure E, Equils O, Sieling PA, Thomas L, Zhang FX, Kirschning CJ, Polentarutti N, Muzio M, and Arditi M. Bacterial lipopolysaccharide activates NF-κB through Toll-like receptor-4 (TLR-4) in cultured human dermal endothelial cells. Differential expression of tlr-4 and tlr-2 in endothelial cells. J Biol Chem 275: 11058-11063, 2000.
62. Fitzgerald KA, Palsson-McDermott EM, Bowie AG, Jefferies CA, Mansell AS, Brady G, Brint E, Dunne A, Gray P, Harte MT, McMurray D, Smith DE, Sims JE, Bird TA, and O'Neill LA. Mal (MyD88-adapter-like) is required for Toll-like receptor-4 signal transduction. Nature 413: 78-83, 2001.
63. Fleury C, Mignotte B, and Vayssiere JL. Mitochondrial reactive oxygen species in cell death signaling. Biochimie 84: 131-141, 2002.
64. Frey EA and Finlay BB. Lipopolysaccharide induces apoptosis in a bovine endothelial cell line via a soluble CD14-dependent pathway. Microb Pathog 24: 101-109, 1998.
65. Fry DE, Pearlstein L, Fulton RL, and Polk HC Jr. Multiple system organ failure. The role of uncontrolled infection. Arch Surg 115: 136-140, 1980.
66. Fujio Y and Walsh K. Akt mediates cytoprotection of endothelial cells by vascular endothelial growth factor in an anchorage-dependent manner. J Biol Chem 274: 16349-16354, 1999.
67. Fujita M, Kuwano K, Kunitake R, Hagimoto N, Miyazaki H, Kaneko Y, Kawasaki M, Maeyama T, and Hara N. Endothelial cell apoptosis in lipopolysaccharide-induced lung injury in mice. Int Arch Allergy Immunol 117: 202-208, 1998.
68. Galle J, Heermeier K, and Wanner C. Atherogenic lipoproteins, oxidative stress, and cell death. Kidney Int Suppl 71: S62-S65, 1999.
69. Gaynor E, Bouvier C, and Spaet TH. Vascular lesions: possible pathogenetic basis of the generalized Shwartzman reaction. Science 170: 986-988, 1970.
70. Geiger M, Stone A, Mason SN, Oldham KT, and Guice KS. Differential nitric oxide production by microvascular and macrovascular endothelial cells. Am J Physiol Lung Cell Mol Physiol 273: L275-L281, 1997.
71. Gerber HP, McMurtrey A, Kowalski J, Yan M, Keyt BA, Dixit V, and Ferrara N. Vascular endothelial growth factor regulates endothelial cell survival through the phosphatidylinositol 3′-kinase/Akt signal transduction pathway. Requirement for Flk-1/KDR activation. J Biol Chem 273: 30336-30343, 1998.
72. 3H]thymidine uptake and circulating endothelial cells in the dog. Exp Mol Pathol 24: 59-69, 1976.
73. Gobe G, Browning J, Howard T, Hogg N, Winterford C, and Cross R. Apoptosis occurs in endothelial cells during hypertension-induced microvascular rarefaction. J Struct Biol 118: 63-72, 1997.
74. Goldblum SE, Brann TW, Ding X, Pugin J, and Tobias PS. Lipopolysaccharide (LPS)-binding protein and soluble CD14 function as accessory molecules for LPS-induced changes in endothelial barrier function, in vitro. J Clin Invest 93: 692-702, 1994.
75. Golenbock DT, Bach RR, Lichenstein H, Juan TS, Tadavarthy A, and Moldow CF. Soluble CD14 promotes LPS activation of CD14-deficient PNH monocytes and endothelial cells. J Lab Clin Med 125: 662-671, 1995.
76. Granville DJ, Carthy CM, Hunt DW, and McManus BM. Apoptosis: molecular aspects of cell death and disease. Lab Invest 78: 893-913, 1998.
77. Grau GE, Mili N, Lou JN, Morel DR, Ricou B, Lucas R, and Suter PM. Phenotypic and functional analysis of pulmonary microvascular endothelial cells from patients with acute respiratory distress syndrome. Lab Invest 74: 761-770, 1996.
78. Gupta K, Kshirsagar S, Li W, Gui L, Ramakrishnan S, Gupta P, Law PY, and Hebbel RP. VEGF prevents apoptosis of human microvascular endothelial cells via opposing effects on MAPK/ERK and SAPK/JNK signaling. Exp Cell Res 247: 495-504, 1999.
79. Gyles CL. Escherichia coli cytotoxins and enterotoxins. Can J Microbiol 38: 734-746, 1992.
80. Hack CE and Zeerleder S. The endothelium in sepsis: source of and a target for inflammation. Crit Care Med 29: S21-S27, 2001.
81. Haendeler J, Zeiher AM, and Dimmeler S. Vitamin C and E prevent lipopolysaccharide-induced apoptosis in human endothelial cells by modulation of Bcl-2 and Bax. Eur J Pharmacol 317: 407-411, 1996.
82. Haimovitz-Friedman A, Cordon-Cardo C, Bayoumy S, Garzotto M, McLoughlin M, Gallily R, Edwards CK III, Schuchman EH, Fuks Z, and Kolesnick R. Lipopolysaccharide induces disseminated endothelial apoptosis requiring ceramide generation. J Exp Med 186: 1831-1841, 1997.
83. Hampton MB and Orrenius S. Dual regulation of caspase activity by hydrogen peroxide: implications for apoptosis. FEBS Lett 414: 552-556, 1997.
84. Harlan JM, Harker LA, Reidy MA, Gajdusek CM, Schwartz SM, and Striker GE. Lipopolysaccharide-mediated bovine endothelial cell injury in vitro. Lab Invest 48: 269-274, 1983.
85. Hawker FH. How to feed patients with sepsis. Curr Opin Crit Care 6: 247-252, 2000.
86. Heimberg H, Heremans Y, Jobin C, Leemans R, Cardozo AK, Darville M, and Eizirik DL. Inhibition of cytokine-induced NF-κB activation by adenovirus-mediated expression of a NF-κB super-repressor prevents β-cell apoptosis. Diabetes 50: 2219-2224, 2001.
87. Higaki A, Ninomiya H, Saji M, Maki H, Koike T, and Ohno K. Protective effect of neurotropin against lipopolysaccharide-induced hypotension and lethality linked to suppression of inducible nitric oxide synthase induction. Jpn J Pharmacol 86: 329-335, 2001.
88. Hinshaw LB. Sepsis/septic shock: participation of the microcirculation: an abbreviated review. Crit Care Med 24: 1072-1078, 1996.
89. Hirata H, Takahashi A, Kobayashi S, Yonehara S, Sawai H, Okazaki T, Yamamoto K, and Sasada M. Caspases are activated in a branched protease cascade and control distinct downstream processes in Fas-induced apoptosis. J Exp Med 187: 587-600, 1998.
90. Hirschfeld M, Ma Y, Weis JH, Vogel SN, and Weis, JJ. Cutting edge: repurification of lipopolysaccharide eliminates signaling through both human and murine Toll-like receptor 2. J Immunol 165: 618-622, 2000.
91. Horng T, Barton GM, and Medzhitov R. TIRAP: an adapter molecule in the Toll signaling pathway. Nat Immun 2: 835-841, 2001.
92. Horng T and Medzhitov R. Drosophila MyD88 is an adapter in the Toll signaling pathway. Proc Natl Acad Sci USA 98: 12654-12658, 2001.
93. Hotchkiss RS, Swanson PE, Cobb JP, Jacobson A, Buchman TG, and Karl IE. Apoptosis in lymphoid and parenchymal cells during sepsis: findings in normal and T- and B-cell-deficient mice. Crit Care Med 25: 1298-1307, 1997.
94. Hoyt DG, Mannix RJ, Gerritsen ME, Watkins SC, Lazo JS, and Pitt BR. Integrins inhibit LPS-induced DNA strand breakage in cultured lung endothelial cells. Am J Physiol Lung Cell Mol Physiol 270: L689-L694, 1996.
95. Hoyt DG, Mannix RJ, Rusnak JM, Pitt BR, and Lazo JS. Collagen is a survival factor against LPS-induced apoptosis in cultured sheep pulmonary artery endothelial cells. Am J Physiol Lung Cell Mol Physiol 269: L171-L177, 1995.
96. Hsu H, Shu HB, Pan MG, and Goeddel DV. TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways. Cell 84: 299-308, 1996.
97. Hu S, Vincenz C, Ni J, Gentz R, and Dixit VM. I-FLICE, a novel inhibitor of tumor necrosis factor receptor-1- and CD95-induced apoptosis. J Biol Chem 272: 17255-17257, 1997.
98. Hu WH, Johnson H, and Shu HB. Activation of NF-κB by FADD, Casper, and caspase-8. J Biol Chem 275: 10838-10844, 2000.
99. Hu X, Yee E, Harlan JM, Wong F, and Karsan A. Lipopolysaccharide induces the antiapoptotic molecules, A1 and A20, in microvascular endothelial cells. Blood 92: 2759-2765, 1998.
100. 2-terminal kinase. J Immunol 169: 2611-2618, 2002.
101. Iglewski BH and Kabat D. NAD-dependent inhibition of protein synthesis by Pseudomonas aeruginosa toxin. Proc Natl Acad Sci USA 72: 2284-2288, 1975.
102. Inohara N, Koseki T, del Peso L, Hu Y, Yee C, Chen S, Carrio R, Merino J, Liu D, Ni J, and Nunez G. Nod1, an Apaf-1-like activator of caspase-9 and nuclear factor-κB. J Biol Chem 274: 14560-14567, 1999.
103. Inohara N, Koseki T, Lin J, del Peso L, Lucas PC, Chen FF, Ogura Y, and Nunez G. An induced proximity model for NF-κB activation in the Nod1/RICK and RIP signaling pathways. J Biol Chem 275: 27823-27831, 2000.
104. Inohara N, Ogura Y, Chen FF, Muto A, and Nunez G. Human Nod1 confers responsiveness to bacterial lipopolysaccharides. J Biol Chem 276: 2551-2554, 2001.
105. Irani K. Oxidant signaling in vascular cell growth, death, and survival: a review of the roles of reactive oxygen species in smooth muscle and endothelial cell mitogenic and apoptotic signaling. Circ Res 87: 179-183, 2000.
106. Irmler M, Thome M, Hahne M, Schneider P, Hofmann K, Steiner V, Bodmer JL, Schroter M, Burns K, Mattmann C, Rimoldi D, French LE, and Tschopp J. Inhibition of death receptor signals by cellular FLIP. Nature 388: 190-195, 1997.
107. Janicke RU, Sprengart ML, Wati MR, and Porter AG. Caspase-3 is required for DNA fragmentation and morphological changes associated with apoptosis. J Biol Chem 273: 9357-9360, 1998.
108. Jersmann HP, Hii CS, Ferrante JV, and Ferrante A. Bacterial lipopolysaccharide and tumor necrosis factor-α synergistically increase expression of human endothelial adhesion molecules through activation of NF-κB and p38 mitogen-activated protein kinase signaling pathways. Infect Immun 69: 1273-1279, 2001.
109. Jirik FR, Podor TJ, Hirano T, Kishimoto T, Loskutoff DJ, Carson DA, and Lotz M. Bacterial lipopolysaccharide and inflammatory mediators augment IL-6 secretion by human endothelial cells. J Immunol 142: 144-147, 1989.
110. Karahashi H and Amano F. Lipopolysaccharide (LPS)-induced cell death of C3H mouse peritoneal macrophages in the presence of cycloheximide: different susceptibilities of C3H/C3I-F HeN and C3H/HeJ mice macrophages. J Endotoxin Res 6: 33-39, 2000.
111. Karahashi H and Amano F. Changes of caspase activities involved in apoptosis of a macrophage-like cell line J774.1/JA-4 treated with lipopolysaccharide (LPS) and cycloheximide. Biol Pharm Bull 23: 140-144, 2000.
112. Karsan A, Yee E, and Harlan JM. Endothelial cell death induced by tumor necrosis factor-α is inhibited by the Bcl-2 family member, A1. J Biol Chem 271: 27201-27204, 1996.
113. Karsan A, Yee E, Kaushansky K, and Harlan JM. Cloning of human Bcl-2 homologue: inflammatory cytokines induce human A1 in cultured endothelial cells. Blood 87: 3089-3096, 1996.
114. Kataoka T, Budd RC, Holler N, Thome M, Martinon F, Irmler M, Burns K, Hahne M, Kennedy N, Kovacsovics M, and Tschopp J. The caspase-8 inhibitor FLIP promotes activation of NF-κB and Erk signaling pathways. Curr Biol 10: 640-648, 2000.
115. Kawai T, Adachi O, Ogawa T, Takeda K, and Akira S. Unresponsiveness of MyD88-deficient mice to endotoxin. Immunity 11: 115-122, 1999.
116. Kawasaki M, Kuwano K, Hagimoto N, Matsuba T, Kunitake R, Tanaka T, Maeyama T, and Hara N. Protection from lethal apoptosis in lipopolysaccharide-induced acute lung injury in mice by a caspase inhibitor. Am J Pathol 157: 597-603, 2000.
117. Kim KY, Kim BG, Kim SO, Yoo SE, Kwak YG, Chae SW, and Hong KW. Prevention of lipopolysaccharide-induced apoptosis by (2S,3S,4R)-N″-cyano-N-(6-amino-3,4-dihydro-3-hydroxy-2-methyl-2- dimethoxym ethyl-2H-benzopyran-4-yl)-N′-benzylguanidine, a benzopyran analog, in endothelial cells. J Pharmacol Exp Ther 300: 535-542, 2002.
118. Kim KY, Shin HK, Choi JM, and Hong KW. Inhibition of lipopolysaccharide-induced apoptosis by cilostazol in human umbilical vein endothelial cells. J Pharmacol Exp Ther 300: 709-715, 2002.
119. Kim YM, Talanian RV, and Billiar TR. Nitric oxide inhibits apoptosis by preventing increases in caspase-3-like activity via two distinct mechanisms. J Biol Chem 272: 31138-31148, 1997.
120. Kiningham KK, Oberley TD, Lin S, Mattingly CA, and St Clair DK. Overexpression of manganese superoxide dismutase protects against mitochondrial-initiated poly(ADP-ribose) polymerase-mediated cell death. FASEB J 13: 1601-1610, 1999.
121. Kirschning CJ, Wesche H, Merrill Ayres T, and Rothe M. Human Toll-like receptor 2 confers responsiveness to bacterial lipopolysaccharide. J Exp Med 188: 2091-2097, 1998.
122. Koide N, Abe K, Narita K, Kato Y, Sugiyama T, Jiang GZ, and Yokochi T. Apoptotic cell death of vascular endothelial cells and renal tubular cells in the generalized Shwartzman reaction. FEMS Immunol Med Microbiol 16: 205-211, 1996.
123. Kong XJ and Fanburg BL. Regulation of Cu,Zn-superoxide dismutase in bovine pulmonary artery endothelial cells. J Cell Physiol 153: 491-497, 1992.
124. Koshi R, Mathan VI, David S, and Mathan MM. Enteric vascular endothelial response to bacterial endotoxin. Int J Exp Pathol 74: 593-601, 1993.
125. Kotamraju S, Chitambar CR, Kalivendi SV, Joseph J, and Kalyanaraman B. Transferrin receptor-dependent iron uptake is responsible for doxorubicin-mediated apoptosis in endothelial cells: role of oxidant-induced iron signaling in apoptosis. J Biol Chem 277: 17179-17187, 2002.
126. Kuang AA, Diehl GE, Zhang J, and Winoto A. FADD is required for DR4- and DR5-mediated apoptosis: lack of trail-induced apoptosis in FADD-deficient mouse embryonic fibroblasts. J Biol Chem 275: 25065-25068, 2000.
127. Kux M, Coalson JJ, Massion WH, and Guenter CA. Pulmonary effects of E. coli endotoxin: role of leukocytes and platelets. Ann Surg 175: 26-34, 1972.
128. LaCasse EC, Baird S, Korneluk RG, and MacKenzie AE. The inhibitors of apoptosis (IAPs) and their emerging role in cancer. Oncogene 17: 3247-3259, 1998.
129. Lang CH, Frost RA, Nairn AC, MacLean DA, and Vary TC. TNF-α impairs heart and skeletal muscle protein synthesis by altering translation initiation. Am J Physiol Endocrinol Metab 282: E336-E347, 2002.
130. Laskin DL, Heck DE, Gardner CR, Feder LS, and Laskin JD. Distinct patterns of nitric oxide production in hepatic macrophages and endothelial cells following acute exposure of rats to endotoxin. J Leukoc Biol 56: 751-758, 1994.
131. Lee YJ and Shacter E. Hydrogen peroxide inhibits activation, not activity, of cellular caspase-3 in vivo. Free Radic Biol Med 29: 684-692, 2000.
132. Lehr HA, Bittinger F, and Kirkpatrick CJ. Microcirculatory dysfunction in sepsis: a pathogenetic basis for therapy? J Pathol 190: 373-386, 2000.
133. Levi M, ten Cate H, van der Poll T, and van Deventer SJ. Pathogenesis of disseminated intravascular coagulation in sepsis. JAMA 270: 975-979, 1993.
134. Li AE, Ito H, Rovira II, Kim KS, Takeda K, Yu ZY, Ferrans VJ, and Finkel T. A role for reactive oxygen species in endothelial cell anoikis. Circ Res 85: 304-310, 1999.
135. Li D, Yang B, and Mehta JL. Ox-LDL induces apoptosis in human coronary artery endothelial cells: role of PKC, PTK, bcl-2, and Fas. Am J Physiol Heart Circ Physiol 275: H568-H576, 1998.
136. Li J, Billiar TR, Talanian RV, and Kim YM. Nitric oxide reversibly inhibits seven members of the caspase family via S-nitrosylation. Biochem Biophys Res Commun 240: 419-424, 1997.
137. Li L, Cousart S, Hu J, and McCall CE. Characterization of interleukin-1 receptor-associated kinase in normal and endotoxin-tolerant cells. J Biol Chem 275: 23340-23345, 2000.
138. Libby P, Ordovas JM, Auger KR, Robbins AH, Birinyi LK, and Dinarello CA. Endotoxin and tumor necrosis factor induce interleukin-1 gene expression in adult human vascular endothelial cells. Am J Pathol 124: 179-185, 1986.
139. Lien E, Means TK, Heine H, Yoshimura A, Kusumoto S, Fukase K, Fenton MJ, Oikawa M, Qureshi N, Monks B, Finberg RW, Ingalls RR, and Golenbock DT. Toll-like receptor 4 imparts ligand-specific recognition of bacterial lipopolysaccharide. J Clin Invest 105: 497-504, 2000.
140. Lopez-Farre A, Rodriguez-Feo JA, Sanchez de Miguel L, Rico L, and Casado S. Role of nitric oxide in the control of apoptosis in the microvasculature. Int J Biochem Cell Biol 30: 1095-1106, 1998.
141. Louise CB and Obrig TG. Shiga toxin-associated hemolytic uremic syndrome: combined cytotoxic effects of shiga toxin and lipopolysaccharide (endotoxin) on human vascular endothelial cells in vitro. Infect Immun 60: 1536-1543, 1992.
142. Macnaughton PD and Evans TW. Management of adult respiratory distress syndrome. Lancet 339: 469-472, 1992.
143. Maeda K, Abello PA, Abraham MR, Wetzel RC, Robotham JL, and Buchman TG. Endotoxin induces organ-specific endothelial cell injury. Shock 3: 46-50, 1995.
144. Martin MA and Silverman HJ. Gram-negative sepsis and the adult respiratory distress syndrome. Clin Infect Dis 14: 1213-1228, 1992.
145. McCuskey RS, Urbaschek R, and Urbaschek B. The microcirculation during endotoxemia. Cardiovasc Res 32: 752-763, 1996.
146. Medzhitov R, Preston-Hurlburt P, Kopp E, Stadlen A, Chen C, Ghosh S, and Janeway CA Jr. MyD88 is an adaptor protein in the hToll/IL-1 receptor family signaling pathways. Mol Cell 2: 253-258, 1998.
147. Messmer UK, Briner VA, and Pfeilschifter J. Tumor necrosis factor-α and lipopolysaccharide induce apoptotic cell death in bovine glomerular endothelial cells. Kidney Int 55: 2322-2337, 1999.
148. Meyrick B. Pathology of the adult respiratory distress syndrome. Crit Care Clin 2: 405-428, 1986.
149. Meyrick BO. Endotoxin-mediated pulmonary endothelial cell injury. Fed Proc 45: 19-24, 1986.
150. Mitchell J, Jiang H, Berry L, and Meyrick B. Effect of antioxidants on lipopolysaccharide-stimulated induction of mangano superoxide dismutase mRNA in bovine pulmonary artery endothelial cells. J Cell Physiol 169: 333-340, 1996.
151. Morita-Fujimura Y, Fujimura M, Yoshimoto T, and Chan PH. Superoxide during reperfusion contributes to caspase-8 expression and apoptosis after transient focal stroke. Stroke 32: 2356-2361, 2001.
152. Munshi N, Fernandis AZ, Cherla RP, Park IW, and Ganju RK. Lipopolysaccharide-induced apoptosis of endothelial cells and its inhibition by vascular endothelial growth factor. J Immunol 168: 5860-5866, 2002.
153. Mutunga M, Fulton B, Bullock R, Batchelor A, Gascoigne A, Gillespie JI, and Baudouin SV. Circulating endothelial cells in patients with septic shock. Am J Respir Crit Care Med 163: 195-200, 2001.
154. Muzio M, Natoli G, Saccani S, Levrero M, and Mantovani A. The human Toll signaling pathway: divergence of nuclear factor-κB and JNK/SAPK activation upstream of tumor necrosis factor receptor-associated factor 6 (TRAF6). J Exp Med 187: 2097-2101, 1998.
155. Muzio M, Stockwell BR, Stennicke HR, Salvesen GS, and Dixit VM. An induced proximity model for caspase-8 activation. J Biol Chem 273: 2926-2930, 1998.
156. Naassila M, Roux F, Beauge F, and Daoust M. Ethanol potentiates lipopolysaccharide- or interleukin-1β-induced nitric oxide generation in RBE4 cells. Eur J Pharmacol 313: 273-277, 1996.
157. Neuzil J, Schroder A, von Hundelshausen P, Zernecke A, Weber T, Gellert N, and Weber C. Inhibition of inflammatory endothelial responses by a pathway involving caspase activation and p65 cleavage. Biochemistry 40: 4686-4692, 2001.
158. O'Loughlin EV and Robins-Browne RM. Effect of Shiga toxin and Shiga-like toxins on eukaryotic cells. Microbes Infect 3: 493-507, 2001.
159. Olson NC, Hellyer PW, and Dodam JR. Mediators and vascular effects in response to endotoxin. Br Vet J 151: 489-522, 1995.
160. Palmer RM, Bridge L, Foxwell NA, and Moncada S. The role of nitric oxide in endothelial cell damage and its inhibition by glucocorticoids. Br J Pharmacol 105; 11-12, 1992.
161. Parsons PE, Worthen GS, Moore EE, Tate RM, and Henson PM. The association of circulating endotoxin with the development of the adult respiratory distress syndrome. Am Rev Respir Dis 140: 294-301, 1989.
162. Pijpers AH, van Setten PA, van den Heuvel LP, Assmann KJ, Dijkman HB, Pennings AH, Monnens LA, and van Hinsbergh VW. Verocytotoxin-induced apoptosis of human microvascular endothelial cells. J Am Soc Nephrol 12: 767-778, 2001.
163. Pinner RW, Teutsch SM, Simonsen L, Klug LA, Graber JM, Clarke MJ, and Berkelman RL. Trends in infectious diseases mortality in the United States. JAMA 275: 189-193, 1996.
164. Pohlman TH and Harlan JM. Human endothelial cell response to lipopolysaccharide, interleukin-1, and tumor necrosis factor is regulated by protein synthesis. Cell Immunol 119: 41-52, 1989.
165. Pohlman TH and Harlan JM. Adaptive responses of the endothelium to stress. J Surg Res 89: 85-119, 2000.
166. Poltorak A, He X, Smirnova I, Liu MY, Huffel CV, Du X, Birdwell D, Alejos E, Silva M, Galanos C, Freudenberg M, Ricciardi-Castagnoli P, Layton B, and Beutler B. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 282: 2085-2088, 1998.
167. Proulx F, Seidman EG, and Karpman D. Pathogenesis of Shiga toxin-associated hemolytic uremic syndrome. Pediatr Res 50: 163-171, 2001.
168. Radomski MW, Palmer RM, and Moncada S. Glucocorticoids inhibit the expression of an inducible, but not the constitutive, nitric oxide synthase in vascular endothelial cells. Proc Natl Acad Sci USA 87: 10043-10047, 1990.
169. Ravagnan L, Roumier T, and Kroemer G. Mitochondria, the killer organelles and their weapons. J Cell Physiol 192: 131-137, 2002.
170. Ray PE and Liu XH. Pathogenesis of Shiga toxin-induced hemolytic uremic syndrome. Pediatr Nephrol 16: 823-839, 2001.
171. Reed JC. Mechanisms of apoptosis. Am J Pathol 157: 1415-1430, 2000.
172. Reidy MA and Schwartz SM. Endothelial injury and regeneration. IV. Endotoxin: a nondenuding injury to aortic endothelium. Lab Invest 48: 25-34, 1983.
173. Rietschel ET, Brade H, Holst O, Brade L, Muller-Loennies S, Mamat U, Zahringer U, Beckmann F, Seydel U, Brandenburg K, Ulmer AJ, Mattern T, Heine H, Schletter J, Loppnow H, Schonbeck U, Flad HD, Hauschildt S, Schade UF, Di Padova F, Kusumoto S, and Schumann RR. Bacterial endotoxin: chemical constitution, biological recognition, host response, and immunological detoxification. Curr Top Microbiol Immunol 216: 39-81, 1996.
174. Rietschel ET, Kirikae T, Schade FU, Mamat U, Schmidt G, Loppnow H, Ulmer AJ, Zahringer U, Seydel U, Di Padova F, Schreier M, and Brade H. Bacterial endotoxin: molecular relationships of structure to activity and function. FASEB J 8: 217-225, 1994.
175. Rockey DC and Chung JJ. Regulation of inducible nitric oxide synthase in hepatic sinusoidal endothelial cells. Am J Physiol Gastrointest Liver Physiol 271: G260-G267, 1996.
176. Rubenstein HS, Fine J, and Coons AH. Localization of endotoxin in the walls of the peripheral vascular system during lethal endotoxemia. Proc Soc Exp Biol Med 111: 458-467, 1962.
177. Rubin DB, Reznik G, Weiss EA, and Young PR. Non-protein thiols flux to S-nitrosothiols in endothelial cells: an LPS redox signal. Shock 14: 200-207, 2000.
178. Ryan KM, Ernst MK, Rice NR, and Vousden KH. Role of NF-κB in p53-mediated programmed cell death. Nature 404: 892-897, 2000.
179. Salvemini D, Korbut R, Anggard E, and Vane J. Immediate release of a nitric oxide-like factor from bovine aortic endothelial cells by Escherichia coli lipopolysaccharide. Proc Natl Acad Sci USA 87: 2593-2597, 1990.
180. Sato I, Kaji K, and Murota S. Age-related decline in cytokine-induced nitric oxide synthase activation and apoptosis in cultured endothelial cells: minimal involvement of nitric oxide in the apoptosis. Mech Ageing Dev 81: 27-36, 1995.
181. Savill JS, Wyllie AH, Henson JE, Walport MJ, Henson PM, and Haslett C. Macrophage phagocytosis of aging neutrophils in inflammation. Programmed cell death in the neutrophil leads to its recognition by macrophages. J Clin Invest 83: 865-875, 1989.
182. Scaffidi C, Schmitz I, Krammer PH, and Peter ME. The role of c-FLIP in modulation of CD95-induced apoptosis. J Biol Chem 274: 1541-1548, 1999.
183. Scatena M, Almeida M, Chaisson ML, Fausto N, Nicosia RF, and Giachelli CM. NF-κB mediates alphavbeta3 integrin-induced endothelial cell survival. J Cell Biol 141: 1083-1093, 1998.
184. Schaub FJ, Han DK, Liles WC, Adams LD, Coats SA, Ramachandran RK, Seifert RA, Schwartz SM, and Bowen-Pope DF. Fas/FADD-mediated activation of a specific program of inflammatory gene expression in vascular smooth muscle cells. Nat Med 6: 790-796, 2000.
185. Schumann RR, Belka C, Reuter D, Lamping N, Kirschning CJ, Weber JR, and Pfeil D. Lipopolysaccharide activates caspase-1 (interleukin-1-converting enzyme) in cultured monocytic and endothelial cells. Blood 91: 577-584, 1998.
186. Schwandner R, Dziarski R, Wesche H, Rothe M, and Kirschning CJ. Peptidoglycan- and lipoteichoic acid-induced cell activation is mediated by Toll-like receptor 2. J Biol Chem 274: 17406-17409, 1999.
187. Sladek Z and Rysanek D. Apoptosis of polymorphonuclear leukocytes of the juvenile bovine mammary gland during induced influx. Vet Res 31: 553-563, 2000.
188. Srinivasula SM, Ahmad M, Ottilie S, Bullrich F, Banks S, Wang Y, Fernandes-Alnemri T, Croce CM, Litwack G, Tomaselli KJ, Armstrong RC, and Alnemri ES. FLAME-1, a novel FADD-like anti-apoptotic molecule that regulates Fas/TNFR1-induced apoptosis. J Biol Chem 272: 18542-18545, 1997.
189. Stefanec T. Endothelial apoptosis: could it have a role in the pathogenesis and treatment of disease? Chest 117: 841-854, 2000.
190. Stehlik C, de Martin R, Kumabashiri I, Schmid JA, Binder BR, and Lipp J. Nuclear factor (NF)-κB-regulated X-chromosome-linked iap gene expression protects endothelial cells from tumor necrosis factor-α-induced apoptosis. J Exp Med 188: 211-216, 1998.
191. Sugawara T, Noshita N, Lewen A, Gasche Y, Ferrand-Drake M, Fujimura M, Morita-Fujimura Y, and Chan PH. Overexpression of copper/zinc superoxide dismutase in transgenic rats protects vulnerable neurons against ischemic damage by blocking the mitochondrial pathway of caspase activation. J Neurosci 22: 209-217, 2002.
192. Sutton ET, Zhou Z, Baker CH, Price JM, and Chen Y. Differences in arterial and arteriolar endothelial structure during endotoxin shock. Circ Shock 41: 71-76, 1993.
193. Suttorp N, Galanos C, and Neuhof H. Endotoxin alters arachidonate metabolism in pulmonary endothelial cells. Am J Physiol Cell Physiol 253: C384-C390, 1987.
194. Swantek JL, Tsen MF, Cobb MH, and Thomas JA. IL-1 receptor-associated kinase modulates host responsiveness to endotoxin. J Immunol 164: 4301-4306, 2000.
195. Takeyama N, Miki S, Hirakawa A, and Tanaka T. Role of the mitochondrial permeability transition and cytochrome c release in hydrogen peroxide-induced apoptosis. Exp Cell Res 274: 16-24, 2002.
196. Tang ZL, Wasserloos KJ, Liu X, Stitt MS, Reynolds IJ, Pitt BR, and St. Croix CM. Nitric oxide decreases the sensitivity of pulmonary endothelial cells to LPS-induced apoptosis in a zinc-dependent fashion. Mol Cell Biochem 234-235: 211-217, 2002.
197. Thijs LG, de Boer JP, de Groot MC, and Hack CE. Coagulation disorders in septic shock. Intensive Care Med 19: S8-S15, 1993.
198. Thornberry NA and Lazebnik Y. Caspases: enemies within. Science 281: 1312-1316, 1998.
199. Tschopp J, Irmler M, and Thome M. Inhibition of fas death signals by FLIPs. Curr Opin Immunol 10: 552-558, 1998.
200. Tzeng E, Kim YM, Pitt BR, Lizonova A, Kovesdi I, and Billiar TR. Adenoviral transfer of the inducible nitric oxide synthase gene blocks endothelial cell apoptosis. Surgery 122: 255-263, 1997.
201. Ulevitch RJ, Cochrane CG, Henson PM, Morrison DC, and Doe WF. Mediation systems in bacterial lipopolysaccharide-induced hypotension and disseminated intravascular coagulation. I. The role of complement. J Exp Med 142: 1570-1590, 1975.
202. Ulevitch RJ and Tobias PS. Receptor-dependent mechanisms of cell stimulation by bacterial endotoxin. Annu Rev Immunol 13: 437-457, 1995.
203. Van Antwerp DJ, Martin SJ, Kafri T, Green DR, and Verma IM. Suppression of TNF-α-induced apoptosis by NF-κB. Science 274: 787-789, 1996.
204. Vescovo G, Zennaro R, Sandri M, Carraro U, Leprotti C, Ceconi C, Ambrosio GB, and Dalla Libera L. Apoptosis of skeletal muscle myofibers and interstitial cells in experimental heart failure. J Mol Cell Cardiol 30: 2449-2459, 1998.
205. Viriyakosol S and Kirkland T. Knowledge of cellular receptors for bacterial endotoxin. Clin Infect Dis 21 Suppl 2: S190-S195, 1995.
206. Visner GA, Block ER, Burr IM, and Nick HS. Regulation of manganese superoxide dismutase in porcine pulmonary artery endothelial cells. Am J Physiol Lung Cell Mol Physiol 260: L444-L449, 1991.
207. Wajant H, Haas E, Schwenzer R, Muhlenbeck F, Kreuz S, Schubert G, Grell M, Smith C, and Scheurich P. Inhibition of death receptor-mediated gene induction by a cycloheximide-sensitive factor occurs at the level of or upstream of Fas-associated death domain protein (FADD). J Biol Chem 275: 24357-24366, 2000.
208. Walter R, Schaffner A, and Schoedon G. Differential regulation of constitutive and inducible nitric oxide production by inflammatory stimuli in murine endothelial cells. Biochem Biophys Res Commun 202: 450-455, 1994.
209. Wang CY, Mayo MW, Korneluk RG, Goeddel DV, and Baldwin AS Jr. NF-κB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation. Science 281: 1680-1683, 1998.
210. Warren HS, Glennon ML, Wainwright N, Amato SF, Black KM, Kirsch SJ, Riveau GR, Whyte RI, Zapol WM, and Novitsky TJ. Binding and neutralization of endotoxin by Limulus antilipopolysaccharide factor. Infect Immun 60: 2506-2513, 1992.
211. Warren HS, Novitsky TJ, Bucklin A, Kania SA, and Siber GR. Endotoxin neutralization with rabbit antisera to Escherichia coli J5 and other gram-negative bacteria. Infect Immun 55: 1668-1673, 1987.
212. Wesche H, Henzel WJ, Shillinglaw W, Li S, and Cao Z. MyD88: an adapter that recruits IRAK to the IL-1 receptor complex. Immunity 7: 837-847, 1997.
213. Williams JM, Boyd B, Nutikka A, Lingwood CA, Barnett Foster DE, Milford DV, and Taylor CM. A comparison of the effects of verocytotoxin-1 on primary human renal cell cultures. Toxicol Lett 105: 47-57, 1999.
214. Wolkow PP. Involvement and dual effects of nitric oxide in septic shock. Inflamm Res 47: 152-166, 1998.
215. Wong GH. Protective roles of cytokines against radiation: induction of mitochondrial MnSOD. Biochim Biophys Acta 1271: 205-209, 1995.
216. Wong HR, Mannix RJ, Rusnak JM, Boota A, Zar H, Watkins SC, Lazo JS, and Pitt BR. The heat-shock response attenuates lipopolysaccharide-mediated apoptosis in cultured sheep pulmonary artery endothelial cells. Am J Respir Cell Mol Biol 15: 745-751, 1996.
217. Wu R, Song X, Xu Y, and Meng X. Apoptosis of endothelial cells in alteration of microvascular permeability in lung during sepsis. Zhonghua Wai Ke Za Zhi 38: 385-387, 2000.
218. Yang RB, Mark MR, Gray A, Huang A, Xie MH, Zhang M, Goddard A, Wood WI, Gurney AL, and Godowski PJ. Toll-like receptor-2 mediates lipopolysaccharide-induced cellular signalling. Nature 395: 284-288, 1998.
219. Yang Z, Breider MA, Carroll RC, Miller MS, and Bochsler PN. Soluble CD14 and lipopolysaccharide-binding protein from bovine serum enable bacterial lipopolysaccharide-mediated cytotoxicity and activation of bovine vascular endothelial cells in vitro. J Leukoc Biol 59: 241-247, 1996.
220. Zen K, Karsan A, Eunson T, Yee E, and Harlan JM. Lipopolysaccharide-induced NF-κB activation in human endothelial cells involves degradation of IκBα but not IκBβ. Exp Cell Res 243: 425-433, 1998.
221. Zen K, Karsan A, Stempien-Otero A, Yee E, Tupper J, Li X, Eunson T, Kay MA, Wilson CB, Winn RK, and Harlan JM. NF-κB activation is required for human endothelial survival during exposure to tumor necrosis factor-α but not to interleukin-1β or lipopolysaccharide. J Biol Chem 274: 28808-28815, 1999.
222. Zhang FX, Kirschning CJ, Mancinelli R, Xu XP, Jin Y, Faure E, Mantovani A, Rothe M, Muzio M, and Arditi M. Bacterial lipopolysaccharide activates nuclear factor-κB through interleukin-1 signaling mediators in cultured human dermal endothelial cells and mononuclear phagocytes. J Biol Chem 274: 7611-7614, 1999.
223. Zhao B, Bowden RA, Stavchansky SA, and Bowman PD. Human endothelial cell response to gram-negative lipopolysaccharide assessed with cDNA microarrays. Am J Physiol Cell Physiol 281: C1587-C1595, 2001.
224. Zhuang S, Lynch MC, and Kochevar IE. Caspase-8 mediates caspase-3 activation and cytochrome c release during singlet oxygen-induced apoptosis of HL-60 cells. Exp Cell Res 250: 203-212, 1999.
225. Ziegler EJ, McCutchan JA, Fierer J, Glauser MP, Sadoff JC, Douglas H, and Braude AI. Treatment of gram-negative bacteremia and shock with human antiserum to a mutant Escherichia coli. N Engl J Med 307: 1225-1230, 1982.